enVVeno Medical Reports Successful Completion of First VenoValve Surgery for U.S. Pivotal Trial
75 Patient Trial Underway to Evaluate Safety and Efficacy of the VenoValve as a Potential Treatment for Severe Deep Venous Chronic Venous Insufficiency (CVI) Severe CVI Impacts Approximately 2.4 million U.S. Patients with No Current Effective Treatment Options enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new